| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Lite Strategy, Inc. | Director | Common Stock | 30K | $56.5K | $1.88 | Nov 19, 2025 | Direct |
| SYNLOGIC, INC. | Director | Common Stock | 15K | $19.4K | $1.29 | Apr 26, 2025 | Direct |
| Lite Strategy, Inc. | Director | Stock Option (Right to Buy) | 55K | Nov 14, 2025 | Direct | ||
| ARCA biopharma, Inc. | Director | Stock Option (right to buy) | 6K | Jan 30, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| LITS | Lite Strategy, Inc. | Nov 19, 2025 | 1 | $22.8K | 4 | Nov 20, 2025 | Director |
| LITS | Lite Strategy, Inc. | Nov 14, 2025 | 1 | $0 | 4 | Nov 18, 2025 | Director |
| LITS | Lite Strategy, Inc. | Oct 1, 2025 | 1 | $25.4K | 4 | Oct 2, 2025 | Director |
| MEIP | MEI Pharma, Inc. | Jul 15, 2025 | 1 | $0 | 4 | Jul 17, 2025 | Director |
| SYBX | SYNLOGIC, INC. | Apr 26, 2025 | 1 | $0 | 4 | Apr 29, 2025 | Director |
| MEIP | MEI Pharma, Inc. | May 16, 2024 | 1 | $25K | 4 | May 20, 2024 | Director |
| SYBX | SYNLOGIC, INC. | Mar 19, 2024 | 1 | $0 | 4 | Mar 21, 2024 | Director |
| SYBX | SYNLOGIC, INC. | Mar 19, 2024 | 0 | $0 | 3 | Mar 21, 2024 | Director |
| ABIO | ARCA biopharma, Inc. | Jan 30, 2024 | 1 | $0 | 4 | Jan 31, 2024 | Director |
| RIBT | RiceBran Technologies | Jan 3, 2024 | 0 | $0 | 3 | Jan 11, 2024 | Director |
| MEIP | MEI Pharma, Inc. | Dec 18, 2023 | 2 | $0 | 4/A | Jan 12, 2024 | Director |
| MEIP | MEI Pharma, Inc. | Dec 18, 2023 | 2 | $0 | 4 | Dec 20, 2023 | Director |
| MEIP | MEI Pharma, Inc. | Oct 31, 2023 | 0 | $0 | 3 | Nov 3, 2023 | Director |
| ABIO | ARCA biopharma, Inc. | Dec 15, 2022 | 1 | $0 | 4 | Dec 19, 2022 | Director |
| ABIO | ARCA biopharma, Inc. | Dec 15, 2022 | 0 | $0 | 3 | Dec 19, 2022 | Director |